HRT Financial LP bought 2,159,052 shares at $0.15 on 2026-06-10, then sold 225,191 shares at $0.12 on 2026-06-11
HRT Financial LP, a 10% owner of Clearmind Medicine, executed 2 separate transactions in consecutive days: purchasing 2,159,052 shares for $330,334.96 at $0.15, followed by a sale of 225,191 shares for $27,698.49 at $0.12. The net effect was a substantial increase of 1,933,861 shares to a post-transaction holding of 1,838,075 shares. The filing occurs amid severe price deterioration—CMND trades at $3.18, down 99.4% from its 52-week high of $524.00 and down 38.8% over 30 days. The company's market cap stands at $502,681.68 ($502.7K), indicating an extremely distressed equity. HRT's cross-ticker track record shows 13 prior buys with a 44.44% 90-day win rate, suggesting modest historical accuracy; however, this particular acquisition is dwarfed by the stock's catastrophic loss of value and the company's microscopic market capitalization, making this one of the most extreme risk events in the filing set.